In this study, we will integrate bioinformatics methodologies with both in vivo and in vitro experiments to investigate the how TRIM32 influences the polarization of macrophages and anti-PD-1 resistance, potentially providing insights into how TRIM32 drives tumor progression and revealing new therapeutic opportunities for GC. This evidence concerns the gene TRIM32 and neoplasm.